ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy

Zohreh Rahimi ¹ *

Cited by CrossRef: 43

1- Yogaprabhu S, Bodhini D, Sneha J, Anjana R, Mohan V, Radha V. Genetics of Diabetic Kidney Disease in Type 2 Diabetes: Candidate Gene Studies and Genome-Wide Association Studies (GWAS). J Indian Inst Sci. 2023;103(1):273 [Crossref]

2- Susilo H, Pikir B, Thaha M, Alsagaff M, Suryantoro S, Wungu C, Wafa I, Pakpahan C, Oceandy D. The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level. Genes. 2022;13(7):1121 [Crossref]

3- Król-Kulikowska M, Abramenko N, Jakubek M, Banasik M, Kepinska M. The Role of Angiotensin-Converting Enzyme (ACE) Polymorphisms in the Risk of Development and Treatment of Diabetic Nephropathy. JCM. 2024;13(4):995 [Crossref]

4- M, Al-Rubeaan K, Sufayran A, Al-Qasim S, Al-Naqeb D. Association of the ACE (rs1800764) Polymorphism with Risk of Diabetic Kidney Disease in Saudi Arabian Population: A Pilot Study using the PCR-RFLP Method. Cytol Genet. 2019;53(6):502 [Crossref]

5- Madyanov I, Yashchenko I, Khabarova O, Opalinskaya I. Analysis of I/D Relationship of Angiotensin-converting Enzyme Gene Polymorphism With Uric Acid Exchange in Patients With Type 2 Diabetes Mellitus (Chuvashia Population). BSP. 2021;7(10):225 [Crossref]

6- Witzel I, Jelinek H, Khalaf K, Lee S, Khandoker A, Alsafar H. Identifying Common Genetic Risk Factors of Diabetic Neuropathies. Front Endocrinol. 2015;6 [Crossref]

7- Nasri H, Rafieian-Kopaei M. Garlic and Kidney Injury Protection. Shiraz E-Med J. 2013;14(4) [Crossref]

8- Pousa P, Mendonça T, Fonseca L, Oliveira E, Belisário A, Simões e Silva A. Evaluation of insertion/deletion (I/D) polymorphisms of ACE gene and circulating levels of angiotensin II in congenital anomalies of the kidney and urinary tract. Mol Biol Rep. 2022;49(6):4341 [Crossref]

9- Trevisano R, Matias H, de Jesus Teani T, Silvino V, Ferreira C, dos Santos M, Braga P, Almeida S. The frequency of the ACE I/D polymorphism in South America: a systematic review and meta-analysis. Mol Cell Biochem. 2024;479(11):2955 [Crossref]

10- Nasri R. Renoprotective effects of metformin. DARU J Pharm Sci. 2013;21(1) [Crossref]

11- Taha M, Mahdy-Abdallah H, Shahy E, Helmy M, ElLaithy L. Diagnostic efficacy of cystatin-c in association with different ACE genes predicting renal insufficiency in T2DM. Sci Rep. 2023;13(1) [Crossref]

12- Ai J, Liu Y, Zeng X, Lei Q, Zou L, Pei B. Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism and Vesicoureteral Reflux in Children. 2015;94(52):e2421 [Crossref]

13- Vikulova O, Zheleznyakova A, Lebedeva N, Nikitin A, Nosikov V, Shestakova M. Genetic factors in the development of chronic kidney disease in patients with diabetes mellitus. Russ J Genet. 2017;53(4):420 [Crossref]

14- Rafieian-Kopaei M, Nasri H. The Ameliorative Effect of Zingiber officinale in Diabetic Nephropathy. Iran Red Crescent Med J. 2014;16(5) [Crossref]

15- Викулова О, Железнякова А, Лебедева Н, Никитин А, Носиков В, Шестакова М. ГЕНЕТИЧЕСКИЕ ФАКТОРЫ В РАЗВИТИИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК ПРИ САХАРНОМ ДИАБЕТЕ, "Генетика". Генетика. 2017;(4):411 [Crossref]

16- Yogi J, Semar A. Association of Hyperuricemia and Urinary Albumin Excretion with Glycosylated Hemoglobin in Patients with Type II Diabetes Mellitus. 2017;2(1):1 [Crossref]

17- Wang Y, Peng L, Lu H, Zhang Z, Xing S, Li D, He C, Jin T, Wang L. Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China. PGPM. 2021;Volume 14:1647 [Crossref]

18- Gutaj P, Matysiak J, Matuszewska E, Jaskiewicz K, Kamińska D, Światły-Błaszkiewicz A, Szczapa T, Kalantarova A, Gajecka M, Wender-Ozegowska E. Maternal serum proteomic profiles of pregnant women with type 1 diabetes. Sci Rep. 2022;12(1) [Crossref]

19- Nasri H. Re Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes. Diabetes & Metabolism. 2013;39(4):375 [Crossref]

20- Davis T, Chubb S, Davis W. The relationship between estimated glomerular filtration rate trajectory and all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study. 2016;175(4):273 [Crossref]

21- Dou X, Cheng H, Meng L, Zhou L, Ke Y, Liu L, Li Y. Correlations between ACE single nucleotide polymorphisms and prognosis of patients with septic shock. 2017;37(2) [Crossref]

22- Kallinikou D, Soldatou A, Tsentidis C, Louraki M, Kanaka‐Gantenbein C, Kanavakis E, Karavanaki K. Diabetic neuropathy in children and adolescents with type 1 diabetes mellitus: Diagnosis, pathogenesis, and associated genetic markers. Diabetes Metabolism Res. 2019;35(7) [Crossref]

23- Iwane S, Nemoto W, Miyamoto T, Hayashi T, Tanaka M, Uchitani K, Muranaka T, Fujitani M, Koizumi Y, Hirata A, Tsubota M, Sekiguchi F, Tan-No K, Kawabata A. Clinical and preclinical evidence that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prevent diabetic peripheral neuropathy. Sci Rep. 2024;14(1) [Crossref]

24- Ali-Bahar H, Mard-Soltani M, Paridar Y, Nasirbaghban Z, Hashemi Z, Zakeri A, Khalili S. Distribution of DD Genotype of Angiotensin-Converting Enzyme Gene and Its Correlation with Diabetic Retinopathy. Trends in Med Sci. 2021;1(2) [Crossref]

25- Nawar A, Alwan Z, Sheikh Q. Gene Expression and Plasma Level of CuZn and Mn Superoxide Dismutase in Iraqi Women with Polycystic Ovary Syndrome. 2022;19(4):691 [Crossref]

26- Kakavandi N, Rezaee S, Hosseini-Fard S, Ghasempour G, Khosravi M, Shabani M, Najafi M. Prostaglandin E2 (PGE2) synthesis pathway is involved in coronary artery stenosis and restenosis. Gene. 2021;765:145131 [Crossref]

27- Kiconco R, Kalyesubula R, Kiwanuka G. Distribution of the ACE Gene Polymorphisms in Type 2 Diabetes Mellitus Patients, Their Associations with Nephropathy Biomarkers and Metabolic Indicators at a Tertiary Hospital in Uganda. DMSO. 2024;Volume 17:2211 [Crossref]

28- Baradaran A. Commentary on: effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes; a randomized double-blind clinical trial. DARU J Pharm Sci. 2013;21(1) [Crossref]

29- Mahwish U, Ponnaluri K, Heera B, Alavala S, Devi K, Raju S, Latha G, Jahan P. Link between ACE I/D gene polymorphism and dyslipidemia in diabetic nephropathy: A case-control study from Hyderabad, India. Indian J Nephrol. 2020;30(2):77 [Crossref]

30- Sharma B, Hussain T, Khan M, Jaiswal V. Exploring AT2R and its Polymorphism in Different Diseases: An Approach to Develop AT2R as a Drug Target beyond Hypertension. CDT. 2022;23(1):99 [Crossref]

31- Gupta P, Mohapatra E, Patel S, Patnayak L, Nanda R, Shah S, Abraham J, Behera A, Jindal A. Effect of the Angiotensin-Converting Enzyme (ACE) (I/D) Polymorphism in COVID-19 Patients and Their Healthy Contacts. 2023; [Crossref]

32- D, Hermawan A, Ikawati Z. Correlation of ACE insertion/deletion gene polymorphism with captopril effectiveness in Indonesian hypertensive patients . Pharmacogenomics. 2024;25(8-9):357 [Crossref]

33- Jankovic M, Novakovic I, Nikolic D, Mitrovic Maksic J, Brankovic S, Petronic I, Cirovic D, Ducic S, Grajic M, Bogicevic D. Genetic and Epigenomic Modifiers of Diabetic Neuropathy. IJMS. 2021;22(9):4887 [Crossref]

34- Mokretar K, Velinov H, Postadzhiyan A, Apostolova M. Association of Polymorphisms in Endothelial Nitric Oxide Synthesis and Renin–Angiotensin–Aldosterone System with Developing of Coronary Artery Disease in Bulgarian Patients. Genetic Testing and Molecular Biomarkers. 2016;20(2):67 [Crossref]

35- Rodriguez V, Chahine A, Parrish M, Alcaide M, Lee T, Hurwitz B, Sawhney M, Weiss S, Jones D, Kumar M. The contribution of syndemic conditions to cardiovascular disease risk. AIDS Care. 2021;33(5):585 [Crossref]

36- Ashour E, Gouda W, Mageed L, Okasha A, Afify M, Fawzi O. Association of gene polymorphisms of ACE, AGT, and ARNT-like protein 1 with susceptibility to gestational diabetes. Egypt J Med Hum Genet. 2022;23(1) [Crossref]

37- Aggarwal N, Kare P, Varshney P, Kalra O, Madhu S, Banerjee B, Yadav A, Raizada A, Tripathi A. Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients. WJD. 2017;8(3):112 [Crossref]

38- Saddick S. Angiotensin converting enzyme gene polymorphism studies: A case-control study. Saudi Journal of Biological Sciences. 2015;22(3):327 [Crossref]

39- Savira M, Savira R, Syahputra M. Association of serum uric acid level and blood pressure in type 2 diabetes mellitus. IOP Conf Ser: Earth Environ Sci. 2018;125:012169 [Crossref]

40- Zou H, Wu G, Lv J, Xu G. Relationship of angiotensin I-converting enzyme (ACE) and bradykinin B2 receptor ( BDKRB2 ) polymorphism with diabetic nephropathy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2017;1863(6):1264 [Crossref]